Disclosure Panels Details Page

Genetic/Familial High-Risk Assessment: Colorectal Panel - Disclosures as of 01/29/2022

Panel Member Clinical Research Support/Data Safety Monitoring Board Scientific Advisory Boards, Consultant, or Expert Witness Promotional Advisory Boards, Consultant, or Speakers Bureau Employment/ Governing Board, Patent, Equity, or Royalty for Panel Member or Dependent Spouse/Domestic Partner/Dependent Potential Conflict Date Completed
Lisen Axell MS None None None None NA 11/12/2021
Marian Birkeland PhD None None None None NA 10/22/2021
Carol Burke MD Emtora biosciences
Freenome inc
Janssen Pharmaceutica Products, LP
freenome inc
SLA pharma
None None NA 12/24/2021
Lee-May Chen MD AstraZeneca Pharmaceuticals LP
Genentech, Inc.
GlaxoSmithKline
None None None NA 10/04/2021
Daniel Chung MD Immunovia
Iterative Scopes
Janssen Pharmaceutica Products, LP
Guardant None None NA 10/18/2021
Katherine Clayback MS,CGC None None None None NA 12/06/2021
Eileen Cucinotta None None None None NA 01/28/2022
Susan Dallas None None None None NA 01/03/2022
Susan Darlow PhD None None None None NA 09/13/2021
Mary Dwyer MS None None None None NA 11/21/2021
Seth Felder MD None None None None NA 12/27/2021
Francis Giardiello MD,MBA None None Steinberg Gastroenterology Board Review Course None NA 11/23/2021
William Grady MD Diacarta
Janssen Pharmaceutica Products, LP
Lucid Technologies
Tempus
Freenome
Guardant Health
SEngine
None None NA 01/15/2022
Kristina Gregory MSN,RN,OCN None None None None NA 11/11/2021
Samir Gupta MD Epigenomics
Freenome
Cellmax
Freenome
Guardant
None None NA 06/23/2021
Michael Hall MD,MS Caris Life Sciences
Invitae
Myriad Genetic Laboratories, Inc.
GRAIL None None NA 12/13/2021
Heather Hampel MS,LGC National Cancer Institute Genome Medical
GI OnDemand
Invitae Genetics
Promega
None None NA 10/05/2021
Rachel Hodan MS,CGC None None None None NA 01/18/2022
Lyen Huang MD,MPH,FACS,FASCRS None None None None NA 01/09/2022
Gregory Idos MD,MS None None None None NA 11/19/2021
Bryson Katona MD,PhD Ambry
Freenome
GeneDx
Guardant
Immunovia
Invitae
Janssen Pharmaceutica Products, LP
Universal Diagnostics
None None None NA 12/28/2021
Moh'D Khushman MD AstraZeneca Pharmaceuticals LP
Bristol-Myers Squibb Company
Ipsen
Taiho Parmaceuticals Co., Ltd. AstraZeneca Pharmaceuticals LP
Pfizer Inc.
None NA 08/23/2021
Laura Lamps MD None None None None NA 01/03/2022
Xavier Llor MD,PhD None None None None NA 11/09/2021
Patrick Lynch MD,JD SLA Pharma SLA Pharma None None NA 11/26/2021
Arnold Markowitz MD None None None None NA 11/12/2021
Sara Pirzadeh-Miller MS None None None None NA 11/29/2021
Donna Powell DHSc,CMD,RT(T) None None None None NA 11/29/2021
Jewel Samadder MD Cancer Prevention Pharmaceuticals
Janssen Pharmaceutica Products, LP
Cancer Prevention Pharmaceuticals
Janssen Pharmaceutica Products, LP
Recursion Pharmaceuticals
None None NA 12/05/2021
David Shibata MD,FACS,FASCRS None None None None NA 11/03/2021
Peter Stanich MD Emtora Biosciences
Freenome
Gaurdant
Invitae Corp.
Janssen Pharmaceutica Products, LP
Pfizer Inc.
PTEN Research foundation
None UpToDate, Inc. Collaborative Group of the Americas on Inherited Gastrointestinal Cancers NA 01/09/2022
Benjamin Swanson MD,PhD None Cogen Bioscience None Cogen Bioscience NA 11/23/2021
Brittany Szymaniak PhD,CGC None "Technology-enhanced AcceleRation of Germline Evaluation for Therapy - The TARGET study" which has been funded by the Prostate Cancer Foundation. UroGPO None NA 11/15/2021
Jennifer Weiss MD,MS Exact Sciences None American College of Physicians
Medscape
None NA 09/12/2021
Jeanna Welborn MD None None None None NA 12/13/2021
Georgia Wiesner MD None None None None NA 12/06/2021
Andrew Wolf MD None None None None NA 01/24/2022
Matthew Yurgelun MD Janssen Pharmaceutica Products, LP UpToDate None None NA 12/13/2021
Mae Zakhour MD None None None None NA 01/03/2022